Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Back

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Infectious Diseases and Therapy|January 10, 2016
Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case ReportsJulie Fox, Michael Brady, Hannah Alexander, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2009
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic studySonia Rodríguez-Nóvoa, Pablo Labarga, Vincent Soriano, et al.
Journal of the International AIDS Society|November 14, 2014
Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implantKimberly Scarsi, Mohammed Lamorde, Kristin Darin, et al.
The Journal of Antimicrobial Chemotherapy|October 19, 2014
Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MSAdeniyi Olagunju, Oluseye O Bolaji, Alieu Amara, et al.
Annals of Internal Medicine|February 28, 2022
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug InteractionsCatia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNADavid M Margolis, Stephen Kewn, Jason J Coull, et al.
AIDS (London, England)|September 27, 2014
No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individualsGurmit J Singh, Akil Jackson, Antonio D'Avolio, et al.
Biomed Research International|February 13, 2018
Aging in HIV-Infected Subjects: A New Scenario and a New ViewEugenia Negredo, David Back, José-Ramón Blanco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 12, 2016
Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure ProphylaxisJulie Fox, Juan M Tiraboschi, Carolina Herrera, et al.
Antiviral Therapy|May 28, 2005
Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapyMarta Boffito, Edward Acosta, David Burger, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Infectious Diseases and Therapy|January 10, 2016
Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case ReportsJulie Fox, Michael Brady, Hannah Alexander, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2009
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic studySonia Rodríguez-Nóvoa, Pablo Labarga, Vincent Soriano, et al.
Journal of the International AIDS Society|November 14, 2014
Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implantKimberly Scarsi, Mohammed Lamorde, Kristin Darin, et al.
The Journal of Antimicrobial Chemotherapy|October 19, 2014
Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MSAdeniyi Olagunju, Oluseye O Bolaji, Alieu Amara, et al.
Annals of Internal Medicine|February 28, 2022
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug InteractionsCatia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNADavid M Margolis, Stephen Kewn, Jason J Coull, et al.
AIDS (London, England)|September 27, 2014
No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individualsGurmit J Singh, Akil Jackson, Antonio D'Avolio, et al.
Biomed Research International|February 13, 2018
Aging in HIV-Infected Subjects: A New Scenario and a New ViewEugenia Negredo, David Back, José-Ramón Blanco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 12, 2016
Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure ProphylaxisJulie Fox, Juan M Tiraboschi, Carolina Herrera, et al.
Antiviral Therapy|May 28, 2005
Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapyMarta Boffito, Edward Acosta, David Burger, et al.
Pageof 15